# Oral Dronabinol-HIV

> **NCT06034314** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Yale University** · enrollment: 160 (estimated)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Dronabinol Capsules

## Key facts

- **NCT ID:** NCT06034314
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-21
- **Primary completion:** 2026-10-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06034314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06034314, "Oral Dronabinol-HIV". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06034314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*